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Abstract
Objective: To describe and compare two age groups’ knowledge of medications linked to falls 
and willingness to change these medications to reduce their fall risk.
Method: We analyzed data from community-dwelling adults age 55 and older (n=1,812), 
including 855 adults aged 55 to 64 years and 957 older adults (65 and older) who participated in 
the 2016 summer wave of the ConsumerStyles survey. ConsumerStyles is an annual web-based 
survey. The data are weighted to match the US Current Population Survey proportions on nine US 
Census Bureau demographic characteristics.
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Measurements: Survey respondents were asked about medication use, knowledge of side 
effects, their willingness to change their medications to reduce fall risk, communication in the 
previous year about fall risk with their healthcare provider, and their comfort in discussing fall risk 
with their healthcare provider. All data were weighted to match the 2016 population estimates. 
Descriptive statistics and chi-square tests (p ≤ 0.05) were used to identify differences between the 
two age groups.
Results: About one-fifth of all respondents reported using at least one class of medication that 
increases fall risk. Older adults were less likely to report using medications for mood or sadness, 
less likely to report knowing the side effects of pain medications, and more willing to change their 
sleep medications compared with their younger counterparts. Among all respondents using these 
medication classes, less than one-third knew the potential fall-related side effects. However, most 
of them expressed willingness to change their medication if advised by their healthcare provider.
Conclusion: Most older adults were unaware of potential fall risks associated with medications 
prescribed to address pain, difficulty sleeping, mood or sadness, and anxiety- or nervousness-
related health issues. However, most were willing to change their medication if recommended by a 
healthcare provider.
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Introduction
Falls impose a large healthcare burden with over 3 million adults ages 65 and over (older 
adults) treated for a fall in an emergency department and more than 850,000 hospitalized in 
2016.1 Among adults ages 55–64, falls resulted in over one million emergency department 
visits and over 152,000 hospitalizations.1 About 2,600 adults ages 55–64 and 29,000 older 
adults died due to a fall in 2016.1 The United States older adult population is projected to 
grow by almost 50% between 2016 and 2030,2 resulting in increased falls and healthcare 
utilization if more is not done to prevent falls.3 Multiple risk factors are associated with falls 
in the aging population, some of which are modifiable such as vestibular disorders, postural 
hypotension, and use of certain medications, and can be targeted to reduce falls.4
In this study, we focused on the use of medications linked to falls. Medications used to treat 
pain (e.g opioid analgesics), sleep disorders (e.g. over-the-counter antihistamines, sedative 
hypnotics), depression (e.g. antidepressants), and anxiety (e.g. benzodiazepines) typically 
affect the central nervous system (CNS-active). They can cause side effects such as 
dizziness, sedation, confusion, blurred vision, and orthostatic hypotension that increase fall 
risk.5 Older adults using CNS-active medications are at an increased risk of more 
pronounced side effects compared with younger adults due to age–related physiologic 
changes accounting for variability in drug metabolism and decreased drug clearance (i.e. 
slower elimination of the drug from the body leading to prolonged exposure).6–8 
Additionally, when taken together, CNS-active medications can have a synergistic effect on 
cognition and physical function.9 Taking multiple CNS-active medications, known as CNS 
polypharmacy, is associated with an increased risk of fall injuries and hospitalizations in 
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older adults. The incident rate ratio for hospitalization for falls in older adults on CNS-active 
medication increased from 1.22 for those on one CNS-active medication to 3.15 for those on 
five or more.10
One way to optimize medication use is to evaluate a patient’s medications routinely for 
potential tapering.11 Tapering or deprescribing is the process of stopping or reducing drugs 
with the goal of managing polypharmacy and improving health outcomes.11 Minimizing 
exposure to CNS-active medications is an important intervention to reduce fall risk in older 
adults. Previous research showed that stopping or reducing the dose of CNS-active 
medications can decrease falls by 66% in older adults.12 Although physician guidelines exist 
on how to stop or reduce CNS-active medications,13,14 tapering can sometimes be 
challenging.
Patient preferences and willingness to taper medications play a central role in deprescribing.
15
 Providers face challenges in tapering medications in older patients because they may have 
different priorities of health goals or inadequate information on the risks and benefits of 
certain medications.16 To our knowledge, there are no studies representative of the U.S. 
population that explore older adults’ willingness to taper medications linked to falls. The 
objectives of this study were to examine adults ages 55–64 and older adults’ knowledge and 
attitudes about medications linked to falls and their willingness to change medications to 
reduce fall risk. We included adults ages 55–64, as they will soon age into a higher risk 
patient population. Additionally, their knowledge of the risks and benefits of specific 
medications could influence how they care for an older loved one.
Methods
ConsumerStyles Survey
The data used in this study came from the summer wave of Porter Novelli’s 2016 
ConsumerStyles survey. The ConsumerStyles survey is built annually from a series of online 
consumer marketing surveys that gather information on health-related attitudes and 
behaviors to inform communication and health promotion activities. The summer wave, 
conducted from June 24 to July 11, 2016, was sent to 6,166 potential respondents who had 
previously completed the spring wave. A total of 4,203 adults (18 and older) completed the 
survey for a response rate of 68%. Study respondents received an honorarium of $5 for 
completing the summer wave survey. The summer wave of ConsumerStyles includes a 
weighting variable that provides a weight for the data to match the U.S. Current Population 
Survey proportions for nine factors: sex, age, household income, race/ethnicity, household 
size, education, census region, and metropolitan status, and whether or not the respondent 
had access to internet prior to joining the panel.17 For the current study, we restricted the 
analysis to adults ages 55 to 64 and age 65 and older (older adults).
Study Variables
Information on the following respondent demographics was recorded: age, sex, race/
ethnicity, education, marital status, income, employment status, and whether they lived in a 
metropolitan statistical area or not. The Census Bureau defines a metropolitan statistical area 
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as a geographical region with high population density and close economic ties. Respondents 
were also asked to report their health status (excellent, very good, good, fair, or poor) and 
whether they had specific health conditions (such as anxiety, arthritis, chronic pain, 
depression, or insomnia).
Survey respondents were asked about medication use. First, they were asked about 
prescription medications ‘How many prescription medications are you currently taking?’ 
and were allowed to input a number between 0 and 99. Then, they were asked a series of 
questions about whether or not they took medications to treat a series of health issues 
typically treated with CNS-medications: 1. ‘Do you take prescription medicine to help you 
with pain?’, 2. ‘Do you take either prescription or over-the-counter medicine to help you 
sleep?’, 3. ‘Do you take prescription medicine to help with your mood or for sadness?’, and 
4. ‘Do you take prescription medicine to help with anxiety or nervousness?’ Individuals who 
said yes, were asked two follow-up questions for each type of medication they reported 
using: 1. ‘Which, if any, of these medicines have side effects (like sleepiness, light-
headedness, or dizziness) that might make you fall?’ and 2. ‘How likely would you be to 
change or reduce your medicine if your doctor thought its side effects (like sleepiness, light-
headedness, or dizziness) might make you fall?’ For the second question, respondents could 
answer on a 4-point Likert scale (very unlikely, somewhat unlikely, somewhat likely, and 
very likely).
All respondents regardless of reported medication use were asked whether someone had 
spoken to them about medications linked to falls in the past 12 months. Finally, they were 
asked with whom they would be comfortable talking to about medications linked to falls. 
Possible answers to both questions included doctor, pharmacist, nurse, another healthcare 
provider, family member or caregiver, or no one, with multiple answers allowed. 
Respondents who reported no prescription medication use and no use of medications to 
address the selected health issues were excluded from the analysis for the last two questions.
Statistical Analysis
All analyses were performed using SPSS Statistics version 23 (SPSS Inc. Chicago, IL). 
Then, Chi-square tests were used to compare the two age groups (55–64 years versus 65+) 
using an alpha of <0.05 to determine statistical differences between groups.
Results
The 1,812 respondents included 855 adults ages 55 to 64 and 957 older adults. Older adults 
were more likely to take five or more medications, more likely to report having arthritis, but 
less likely to report having anxiety and depression compared to adults age 55–64 (Table 1).
Approximately one-fifth (21.1%) of all respondents in the sample (all adults 55 and older) 
reported using medications to treat pain, followed by sleep disorder (17.9%), mood or 
sadness (10.0%), and anxiety (9.8%) medications (Table 2). Among those reporting use of a 
medication class, less than one-third of respondents reported knowledge of fall related side 
effects (Table 2). However, most were willing to change their medication if recommended by 
their doctor to reduce fall risk (Figure 1). Older adults were less likely to report using mood 
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or sadness medications, less likely to report knowing the side effects of pain medications, 
and more willing to change their sleep medication compared with their younger counterparts 
(Table 2). There were no other statistically significant differences between the age groups in 
knowledge of side effects and willingness to change their medication use.
Among respondents who reported who reported medication use, 85% of adults ages 55 to 64 
and 81.9% of older adults reported not talking to anyone in the past 12 months about 
medications that might make them fall (Figure 2A). Of the respondents taking one or more 
prescription medications, more than 80% reported being comfortable talking to their doctor, 
and approximately 40% reported being comfortable talking to a pharmacist or nurse about 
medications that may make them fall (Figure 2B). A limited number of respondents stated 
they would not be comfortable discussing medications and fall risk with anyone.
Discussion
In our study, about one-quarter of adults ages 55 to 64 and one-fifth of older adults reported 
using one of the medications to treat a health issue typically treated with CNS-active 
medications. However, less than a third of those who reported use also reported knowledge 
of potential fall-related side effects associated with each medication type. Importantly, we 
found that the majority of respondents would be willing to change a medication that 
increases fall risk if recommended by a healthcare provider. CNS-active medications, 
including opioid-receptor agonists, benzodiazepines, sedative hypnotics, and 
antidepressants, have side effects that alter cognition and physical function and are 
associated with falls and fall recurrence in older adults.5, 18 Physiological changes with 
advancing age may account for variability in drug metabolism and decreased drug clearance 
potentially leading to more pronounced adverse drug events in older adults.6 Provider-driven 
patient education on medication-related side effects and fall risk could encourage patients 
and providers to work together and optimize medication use.
Older adults were more likely to report using a higher number of medications compared 
with adults ages 55 to 64. Previous studies have shown polypharmacy was independently 
associated with a significant decline in cognitive and physical capability,19 and increased 
risk of falls (14% increase in fall risk with the each medication added beyond 4 
medications).20 Therefore, targeting older adults for tapering unnecessary medication has 
potential health benefits. Providers who participated in a qualitative study regarding 
polypharmacy acknowledged a number of factors as potential barriers to tapering.16, 21 
These included their hesitancy to stop medications prescribed by other physicians, patients’ 
strong beliefs in their medications, concerns about the health consequences of stopping 
certain medications, and the need to follow clinical guidelines which often influence the 
number of medications needed to manage a disease state.21 Providers also reported concerns 
about applying guideline-directed care in older adults due to the difficulty of performing risk 
stratification for individual patients and balancing the benefits and harms to older patients.16 
Better tools are needed to quantify risks and benefits of medication use in older adults and to 
give healthcare providers guidance on how to communicate these issues to patients.
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Tapering of CNS-active medications is feasible and has a clear benefit in reducing risk of 
falls and injuries in older adults. Stopping CNS-active medications, including 
benzodiazepines, was shown to be associated with improved cognition, improved 
psychomotor activity and a reduction in falls.22 Moreover, the EMPOWER cluster 
randomized trial found that pharmacist-driven medication education to patients led to a 
reduction of benzodiazepine use by 77% without withdrawal symptoms.23 Healthcare 
providers can take the initial step by educating patients on the dangers of CNS-active 
therapies and the health benefits of tapering unnecessary medications while maintaining 
appropriate care for patient health. Our findings indicate that older adults are willing to 
change a medication with appropriate provider guidance. This confirms previous reports that 
patients trust their providers to make decisions about their prescription medications and will 
discontinue medications at their provider’s recommendation.24, 25
Given patient willingness to discuss fall risk, healthcare providers should routinely initiate 
the conversation by screening for fall risk, assessing the patient’s modifiable fall risk factors, 
and intervening to reduce risk by using evidence-based strategies, including the effective 
management of medications linked to falls.15 Falls risk screening and assessment can be 
conducted and reimbursed as part of the Medicare Annual Wellness Visit.26 In addition, falls 
risk screening, including a medication assessment, is a quality measure under the Medicare 
Access and CHIP Reauthorization ACT (MACRA), which offers value-based reimbursement 
for services through a Merit based Incentive Payment System (MIPS).26 Furthermore, 
Centers for Disease Control and Prevention developed the Stopping Elderly Accidents, 
Deaths, and Injuries (STEADI) initiative, based on the American and British Geriatrics 
Societies’ clinical practice guidelines, to provide tools and resources to assist healthcare 
providers with fall prevention.27 Resources related to medication management include the 
Screen, Assess, Facilitate, and Educate (SAFE) approach, highlighting steps for a targeted 
medication review, and the Medications Linked to Falls factsheet, providing guidance on 
managing high-risk medications in older adults (www.CDC.GOV/STEADI). With quality 
measures in place and resources available, providers are incentivized and well equipped to 
engage in fall-risk screenings, including medication assessment. Documenting any attempt 
to taper medications (including complete cessation or dose reduction) of fall-risk increasing 
drugs or rationale for why tapering is not warranted enables evaluation of the impact of 
medication management on falls and can help justify medication management as an effective 
strategy. Given the complexity of falls as a geriatric syndrome, these efforts must continue 
long term to implement a fall-risk reduction strategy.
Patient-engaged conversations on tapering with healthcare providers have been associated 
with increased patient knowledge and information seeking behaviors about medication 
related harms and openness to tapering potentially harmful medications.28 The Patient 
Activation Measure (PAM), developed at the University of Oregon, can measure a patient’s 
ability to manage their own health by assessing knowledge, skill, and level of confidence to 
manage their own health.29, 30 This measure can be used to tailor individual patient 
interventions to reduce medication harms and adverse events. Previous studies show that 
patients with higher scores on PAM are more likely to engage in preventive behaviors, 
adhere to treatment regimens, and obtain regular healthcare screenings.29, 31 Highly 
activated patients are more likely to have better health outcomes and lower healthcare costs 
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due to the reduced need for hospitalizations and emergency department visits as compared to 
less activated patients.31–33
Our study has limitations. First, the sampling approach used by ConsumerStyles is not 
random. The dataset is weighted to be representative of the U.S. population based on 
selected factors only; nonetheless, research comparing consumer panel data with national 
population probability sampling data supports the use of ConsumerStyles data.34 Second, 
medication use was self-reported and may be underestimated due to social desirability bias 
of underreporting CNS-active medications.35 Third, knowledge of medication side effects 
and attitude towards medication stopping or tapering was also self-reported and may have 
been overestimated. Finally, our analyses combined all older adults age 65 and older as one 
group due to a small sample size in older ages. Future studies are needed to explore 
willingness to change medications linked to falls among older adults in the oldest age 
categories (75–84 and 85+).
In conclusion, with the exception of knowledge of the side effects of pain medications, and 
reported willingness to change sleep medications, both age groups reported similar 
knowledge and attitudes. Most older adults are unaware of the fall risks associated with 
medications used for certain health issues including pain, difficulty sleeping, mood or 
sadness, anxiety or nervousness but they are willing to change medication if a healthcare 
provider communicates the risk. Patient and provider awareness about fall-risk increasing 
drugs, including CNS-active medications, and guidance on tapering and medication 
management may help lower the risk of adverse drug events, falls, injuries and deaths.
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Impact Statement
We certify that this work is novel. Our research aimed to understand older adult attitudes 
toward medications linked to increased fall risk, and their openness to tapering. The 
majority of respondents were unaware of the fall risk associated with medications they 
took to address pain, difficulty sleeping, mood or sadness, anxiety or nervousness but 
were willing to change their medications to reduce their fall risk if their healthcare 
provider advised them to change.
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Figure 1: 
Willingness to change fall-related medications: comparison of age groups.
Source: ConsumerStyles 2016.
*Only respondents reporting use of medication class per health condition were included
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Figure 2: 
Provider-patient communication on medicines linked to falls by provider type
Source: ConsumerStyles 2016
Respondents reporting no prescription medication use and no use of medications to address 
selected health issues were excluded (total unweighted count= 1417; age 55-64 n=610; age 
≥65 n=807).
2A: Respondents reported previous communication with provider about medicines that may 
increase fall risk.
2B: Respondents reported to whom they would be comfortable talking.
a
 Categories are not mutually exclusive.
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*
 Estimate is unstable due to small sample size (unweighted n<20).
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Table 1.
Demographic, health and medication characteristics of adults age 55 and older.
Total Sample
(55 years and older)
unweighted n = 1812
Adults age
55–64 years old
unweighted n = 855
Adults age
65 years and older
unweighted n = 957
Respondent Demographics Unweighted n Weighted
%a
Unweighted n Weighted
%a
Unweighted n Weighted
%a P-valueb
Gender 0.163
Male 891 46.2 424 48.1 467 44.5
Female 921 53.8 431 51.9 490 55.5
Race/Ethnicity 0.18
Non-Hispanic White 1446 71.3 660 69.3 786 72.9
Non-Hispanic Black 165 11.6 91 13.2 74 10.3
Other including Hispanic 201 17.1 104 17.5 97 16.8
Education 0.216
<High School 134 14.1 57 12.5 77 15.5
High School/College no Degree 1009 61.3 461 62.9 548 59.9
≥College 669 24.6 337 24.6 332 24.6
Marital Status 0.958
Married 1118 62.0 529 61.9 589 62.1
Not Married 694 38.0 326 38.1 368 37.9
Income ($) <0.001
<19,999 277 15.4 164 19.1 113 12.0
20,000–59,999 706 35.0 253 27.2 453 41.9
60,000–99,999 392 25.8 205 27.1 187 24.7
≥ 100,000 437 23.8 233 26.6 204 21.4
Employment <0.001
Employed 661 35.9 501 57.2 160 17.3
Not Employed 1151 64.1 354 42.8 797 82.7
Residential Location c 0.141
Non-metropolitan Area 288 16.2 144 17.0 144 15.5
Metropolitan Area 1524 83.8 711 83.0 813 84.5
Self-reported Health Status d 0.414
Very Good/ Excellent 745 39.6 344 37.8 401 41.2
Good 724 41.2 356 44.2 368 38.6
Fair 281 15.8 123 14.4 158 16.9
Poor 60 3.4 32 3.5 28 3.4
Self-reported Health Issue d
Anxiety 228 12.0 131 14.7 97 9.6 0.003
Arthritis 590 32.9 222 27.7 368 37.4 <0.001
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Total Sample
(55 years and older)
unweighted n = 1812
Adults age
55–64 years old
unweighted n = 855
Adults age
65 years and older
unweighted n = 957
Respondent Demographics Unweighted n Weighted
%a
Unweighted n Weighted
%a
Unweighted n Weighted
%a P-valueb
Chronic Pain 305 16.3 144 16.5 161 16 0.780
Depression 202 10.2 126 13.4 76 7.4 <0.001
Insomnia 198 10.0 103 10.2 95 9.8 0.797
Number of Prescription Medications Currently Taking d <0.001
0 379 21.1 240 28.7 139 14.4
1 – 4 933 52.3 418 49.4 515 54.9
≥ 5 491 26.6 193 21.9 298 30.8
a
Data are weighted to match the US Current Population Survey proportions of the US population according to census measures.
b
The P-value is a comparison between the two age groups: 55 to 64 and 65 and older.
c
The metropolitan variable is classified as being in a metropolitan statistical area or not, based on US Census Bureau population density standards.
d
Respondents were not required to answer any of the questions and could exit the survey at any time.
Source: ConsumerStyles 2016.
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